Functional neurological recovery after spinal cord injury is impaired in patients with infections

Brain

Volumn 135, Issue 11, 2012, Pages 3238-3250

  Failli, Vieri ^a   Kopp, Marcel A ^a   Gericke, Christine ^a   Martus, Peter ^a,b   Klingbeil, Susann ^a,c   Brommer, Benedikt ^a   Laginha, Inês ^a   Chen, Yuying ^d   Devivo, Michael J ^d   Dirnagl, Ulrich ^a   Schwab, Jan M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d University of Alabama at Birmingham   (United States)

Author keywords

intrinsic endogenous recovery potential; neurological recovery; poor outcome

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION;

EID: 84870221733     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws267     Document Type: Article

References (44)

1. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res 2007; 161: 125-41.
2. Burns AS, Lee BS, Ditunno JF Jr, Tessler A. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma 2003; 20: 477-82.
3. Curt A, Van Hedel HJ, Klaus D, Dietz V, EM-SCI Study Group. Recovery from a spinal cord injury: significance of compensation, neural plasticity, and repair. J Neurotrauma 2008; 25: 677-85.
4. DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil 1999; 80: 1411-19.
5. DeVivo MJ, Go BK, Jackson AB. Overview of the national spinal cord injury statistical center database. J Spinal Cord Med 2002; 25: 335-8. (Pubitemid 37486176)
6. Dobkin BH. Confounders in rehabilitation trials of task-oriented training: lessons from the designs of the EXCITE and SCILT multicenter trials. Neurorehabil Neural Repair 2007a; 21: 3-13. (Pubitemid 44926967)
7. Dobkin BH. Curiosity and cure: translational research strategies for neural repair-mediated rehabilitation. Dev Neurobiol 2007b; 67: 1133-47.
8. Dobkin BH. Motor rehabilitation after stroke, traumatic brain, and spinal cord injury: common denominators within recent clinical trials. Curr Opin Neurol 2009; 22: 563-9.
9. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190-205.
10. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011; 77: 1338-45.
11. Fouad K, Krajacic A, Tetzlaff W. Spinal cord injury and plasticity: opportunities and challenges. Brain Res Bull 2011; 84: 337-42.
12. Furlan JC, Krassioukov AV, Fehlings MG. Hematologic abnormalities within the first week after acute isolated traumatic cervical spinal cord injury: a case-control cohort study. Spine 2006; 31: 2674-83.
13. Furlan JC, Fehlings MG, Tator CH, Davis AM. Motor and sensory assessment of patients in clinical trials for pharmacological therapy of acute spinal cord injury: psychometric properties of the ASIA Standards. J Neurotrauma 2008; 25: 1273-301.
14. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-34.
15. Held KS, Steward O, Blanc C, Lane TE. Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection. Exp Neurol 2010; 226: 242-53.
16. Koennecke HC, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011; 77: 965-72.
17. Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 2007; 207: 75-84.
18. Marino RJ, Ditunno JF Jr, Donovan WH, Maynard F Jr. Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems. Arch Phys Med Rehabil 1999; 80: 1391-6. (Pubitemid 29526635)
19. Marino RJ. International standards for neurological classification of spinal cord injury. J Spinal Cord Med 2003; 26 (Suppl 1): S50-6.
20. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-And neutrophil-dependent mechanisms. J Neurosci 2007; 27: 4403-12.
21. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 2008; 28: 9451-62.
22. Meisel C, Prass K, Braun J, Victorov I, Wolf T, Megow D, et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 2004; 35: 2-6. (Pubitemid 38057579)
23. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-86.
24. Moreno B, Jukes JP, Vergara-Irigaray N, Errea O, Villoslada P, Perry VH, et al. Systemic inflammation induces axon injury during brain inflammation. Ann Neurol 2011; 70: 932-42.
25. Oropallo MA, Held KS, Goenka R, Ahmad SA, O'Neill PJ, Steward O, et al. Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in mice. J Immunol 2012; 188: 5257-66.
26. Perry VH, Newman TA, Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 2003; 4: 103-12.
27. Popovich P, McTigue D. Damage control in the nervous system: beware the immune system in spinal cord injury. Nat Med 2009; 15: 736-7.
28. Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2001; 2: 263-73.
29. Richards JS, Go BK, Rutt RD, Lazarus PB. The national spinal cord injury collaborative database. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord injury: clinical outcomes from the model systems. Gaithersburg, MD: Aspen Publishers; 1995. p. 10-20.
30. Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, et al. Hematologic cellular inFammatory response following human spinal cord injury [abstract]. Acta Neuropathol 2003; 106: 392.
31. Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci 2007; 25: 1743-7. (Pubitemid 46550016)
32. Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, et al. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience 2009; 158: 1194-9.
33. Schnell L, Schneider R, Berman MA, Perry VH, Schwab ME. Lymphocyte recruitment following spinal cord injury in mice is altered by prior viral exposure. Eur J Neurosci 1997; 9: 1000-7. (Pubitemid 27226463)
34. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001; 26 (Suppl 24): S2-12.
35. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, et al. International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-21.
36. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, et al. Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord 2011; 49: 257-65.
37. Stover SL, DeVivo MJ, Go BK. History, implementation, and current status of the National Spinal Cord Injury Database. Arch Phys Med Rehabil 1999; 80: 1365-71.
38. Urra X, Villamor N, Amaro S, Gó mez-Choco M, Obach V, Oleaga L, et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab 2009; 29: 994-1002.
39. Vega JL, Ganea D, Jonakait GM. Acute down-regulation of antibody production following spinal cord injury: role of systemic catecholamines. J Neuropathol Exp Neurol 2003; 62: 848-54.
40. Vermeij FH, Scholte op Reimer WJ, de Man P, van Oostenbrugge RJ, Franke CL, de Jong G, et al. Stroke-Associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009; 27: 465-71.
41. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-Analysis. BMC Neurol 2011; 11: 110.
42. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease -A double-edged sword. Neuron 2002; 35: 419-32.
43. Zariffa J, Kramer JL, Fawcett JW, Lammertse DP, Blight AR, Guest J, et al. Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury. Spinal Cord 2011; 49: 463-71.
44. Zörner B, Blanckenhorn WU, Dietz V, EM-SCI Study Group, Curt A. Clinical algorithm for improved prediction of ambulation and patient stratification after incomplete spinal cord injury. J Neurotrauma 2010; 27: 241-52.